Page last updated: 2024-08-17

levodopa and Behavior Disorders

levodopa has been researched along with Behavior Disorders in 103 studies

Research

Studies (103)

Timeframe	Studies, this research(%)	All Research%
pre-1990	51 (49.51)	18.7374
1990's	9 (8.74)	18.2507
2000's	19 (18.45)	29.6817
2010's	22 (21.36)	24.3611
2020's	2 (1.94)	2.80

Authors

Authors	Studies
Chiu, R; Frank, C; Lee, J	1
Gundersen, V; Jusufovic, M; Luth, SM; Nysveen, I; Skogseid, IM	1
Amorim, BJ; Barsottini, OGP; Faber, I; França, MC; Friedman, JH; Lopes-Cendes, Í; Lourenço, CM; Maia, ML; Marques, W; Martinez, ARM; Martins, CR; Montecchiani, C; Orlacchio, A; Pedroso, JL; Ramos, CD; Souza, JP	1
Drapier, D; Drapier, S; Duprez, J; Houvenaghel, JF; Riou, A; Robert, GH; Sauleau, P; Vérin, M	1
Chen, SY; Hsieh, TC; Hung, HY; Lin, SH; Lin, SZ; Tsai, ST	1
Corona-Morales, AA; Hernández, VS; Jáuregui-Huerta, F; Luquín, S; Medina, MP; Ruíz-Velasco, S; Zhang, L	1
Kulisevsky, J; Pagonabarraga, J	1
Brotchie, JM; Fox, SH; Huot, P; Johnston, TH; Koprich, JB; Lewis, KD; Piggott, MJ; Reyes, MG	1
Fernández-Bobadilla, R; Gironell, A; Kulisevsky, J; Martínez-Horta, S; Pagonabarraga, J; Pascual-Sedano, B; Pérez-Pérez, J; Sierra, S	1
Ballanger, B; Bars, DL; Beaudoin-Gobert, M; Bonnefoi, F; Broussolle, E; Costes, N; Duperrier, S; Epinat, J; Lavenne, F; Liger, F; Météreau, E; Neumane, S; Sgambato-Faure, V; Thobois, S; Tourvielle, C; Tremblay, L	1
Evans, AH; Looi, JC; Molina Ruiz, RM; Velakoulis, D	1
Balaz, M; Chrastina, J; Feitova, V; Hrabovsky, D; Hummelova, Z; Novak, Z; Rab, M	1
Brandabur, M; Goetz, CG; Goldman, JG; Sanfilippo, M; Stebbins, GT	1
Kulisevsky, J; Martinez-Corral, M; Pagonabarraga, J	1
Bhatia, KP; Davis, MB; Edwards, MJ; Gerhard, A; Hanna, MG; Mir, P; Polke, JM; Schwingenschuh, P; Sweeney, MG; Trender-Gerhard, I; Wood, NW	1
Ding-Fang, C; Guo-Hua, W; Hong-Min, T; Hua-Wei, L; Jun, M; Jun-Peng, G; Shan, S; Wen-Wei, L; Xiang-Yu, W; Ya-Ling, H; Yan-Hong, T; Yi, F; Yue, F; Yun-Ke, Y	1
Stacy, M	1
Berrocal-Izquierdo, N; Castrillo-Sanz, A; Martínez-Pueyo, A; Rodríguez-Vico, JS	1
Ivanov, AK; Levin, OS; Smolentseva, IG	1
Belcastro, V; Calabresi, P; Castrioto, A; Gallina, A; Rossi, A; Tambasco, N	1
Bugalho, P; Cargaleiro, I; da Silva, JA; Neto, B; Serra, M	1
Heimrath, J; Kassubek, J; Ludolph, AC; Lulé, D; Pinkhardt, EH; Uttner, I	1
Grohmann, R; Haueis, P; Jaquenoud Sirot, E; Kullak-Ublick, GA; Russmann, H; Russmann, S; Zorina, OI	1
Hebb, AO; Hu, SC	1
Chouinard, S; Gagnon, JF; Latreille, V; Montplaisir, J; Panniset, M; Postuma, RB; Romenets, SR	1
Ait Benhaddou, EH; Benjelloun, H; Benomar, A; Lachhab, L; Razine, R; Regragui, W; Yahyaoui, M	1
Bravo-Utrera, M; Burguera, JA; Campos-Arillo, VM; Chacón, JR; Durán-Herrera, C; Fernández-García, JM; García-Ramos, R; García-Ruiz, PJ; Gómez-Esteban, JC; Grandas, FJ; Gutierrez, J; Juni, J; Luquin, MR; Martí, MJ; Martínez-Castrillo, JC; Mata, M; Olivares, J; Ribacoba-Montero, R; Rojo, A; Santos-García, D; Sierra, M; Valero-Merino, C; Vela, L	1
Barker, RA; Brooks, DJ; Burn, DJ; Coleman, S; Duncan, GW; Khoo, TK; O'Brien, JT; Yarnall, AJ	1
Ikemoto, K	2
Bhatia, KP; Critchley, P; Graham, E; Khan, NL; Lees, AJ; Quinn, N; Schrag, AE; Wood, NW	1
Nakatsuka, A; Nomoto, M	1
Hirato, M; Kita, K; Kondo, T; Okamoto, K; Yuasa, T	1
Mitsuyama, Y	1
Ahlskog, JE; Bower, JH; Josephs, KA; Klos, KJ; Matsumoto, JY	1
Le Rhun, E; Lebert, F	1
Diamond, A; Jankovic, J	1
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Visanji, NP; Voon, V	1
Miller, EM; Nieburg, HA	1
Vieregge, P	1
Frackowiak, RS; Gibbs, JM; Jones, T; Lammertsma, AA; Leenders, KL	1
Quinn, NP	1
Mouren, A; Mouren, P; Nguyen Quang, N; Oppenheim, G; Poinso, Y	1
Coignet, A; de Recondo, J; Rondot, P; Ziegler, M	1
Baum, R; Glantz, R; Klawans, HL; Nausieda, PA; Weber, S	1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Thompson, C	1
Rinne, UK	1
Lehmann, J	1
Parkes, JD	1
Piccinin, GL; Piccirilli, M	1
Berezhnaia, VA; Nuller, IuL; Ostroumova, MN	1
Dziatolowski, M; Gopinathan, G; Korein, J; Kupersmith, M; Lieberman, A; Neophytides, A	1
Liu, DK	1
Lees, AJ; Shaw, KM; Stern, GM	1
Korczyn, AD; Neufeld, MY; Orlov, E; Rabey, JM; Treves, TA	1
Marsden, CD; Nordera, G; Stocchi, F	1
Bowers, MB	1
Bravo, G; Brera, B; Dargallo, J; Insausti, J; López-Lozano, JJ; Millán, I; Salmeán, J; Uría, J	1
Castro-García, A	1
Rascol, O	1
King, DB	1
Bonanni, L; Di Iorio, A; Iacono, D; Onofrj, M; Thomas, A	1
Carlsson, A	1
Aktan, S; Bekiroglu, N; Gunal, DI; Nurichalichi, K; Tuncer, N	1
Bergamasco, B; Lanotte, M; Lopiano, L; Perozzo, P; Rizzone, M; Tavella, A; Torre, E	1
Lloyd, KG	2
Bissette, G; Lipton, MA; Loosen, PT; Manberg, PJ; Nemeroff, CB; Prange, AJ; Wilson, IC	1
Hartmann, E; Keller-Teschke, M	2
Biswas, PN; Sarker, SK	1
Reus, VI	1
Klawans, HL; Moskovitz, C; Nausieda, PA; Weiner, WJ	1
Chatelanat, P	1
Gershon, S; Shopsin, B	1
Barbeau, A; Gonce, M	1
Bianchine, JR; Shaw, GM	1
Bunney, WE	1
Duvoisin, RC	1
Feigenson, JS; Goodell, H; Loranger, AW; McDowell, FH; Sweet, RD	1
Csaba, B; László, V	1
Dolezalová, B; Vacek, J	1
Goodgold, A; Jonas, S; Leibowitz, M; Lieberman, A	1
Presthus, J	1
Castaigne, P	1
Barbeau, A; Botez, MI	1
Goodell, H; Loranger, A; McDowell, F; Sweet, RD	1
Pfeiffer, R	1
Montastruc, JL; Rascol, A; Rascol, O	1
Carlson, GA; Krahn, DD; Levine, AS; Morley, JE; Shafer, RB; Willenbring, ML	1
Guillard, A	1
Dubois, B	1
Fernandez Pardal, M; Gatto, M; Micheli, F; Perez y Gonzalez, N	1
García, S; Gershanik, OS; Scipioni, O	1
Klawans, HL	1
Harvey, NS	1
Grau-Veciana, JM; Peiró Grasa, A	1
AuAutret, A	1
Ferrari, E	1
Holmsen, R; Presthus, J	1
Il'inskiĭ, IA; Safronov, VA; Vasin, NIa	1
Harrison, MJ; Marsden, CD	1
Feldman, RD; Pearlman, CA; Sax, DS	1

Reviews

28 review(s) available for levodopa and Behavior Disorders

Article	Year
[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?]. Revista de neurologia, 2014, Jan-01, Volume: 58, Issue:1 Topics: Amantadine; Antiparkinson Agents; Cardiovascular Diseases; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Clinical Trials as Topic; Dopamine Agonists; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Food-Drug Interactions; Humans; Indans; Indoles; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Parkinson Disease; Serotonin Syndrome; Treatment Outcome	2014
A guide to management of neuropsychiatric manifestations of Parkinson's disease. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2016, Volume: 24, Issue:6 Topics: Humans; Levodopa; Mental Disorders; Parkinson Disease; Practice Guidelines as Topic; Psychotropic Drugs	2016
[Dopaminergic stimulation in the non-motor symptoms of Parkinson's disease]. Revista de neurologia, 2010, Feb-08, Volume: 50 Suppl 2 Topics: Autonomic Nervous System Diseases; Digestive System Diseases; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Levodopa; Mental Disorders; Parkinson Disease; REM Sleep Parasomnias; Sexual Dysfunction, Physiological; Sleep Apnea Syndromes; Urologic Diseases	2010
[Non-motor fluctuations in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:3 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Humans; Levodopa; Mental Disorders; Motor Activity; Parkinson Disease; Somatosensory Disorders	2010
[Levodopa in the treatment of Parkinson's disease: myths and realties]. Revista de neurologia, 2012, Dec-01, Volume: 55, Issue:11 Topics: Antiparkinson Agents; Humans; Levodopa; Mental Disorders; Motor Activity; Parkinson Disease; Quality of Life; Sleep Wake Disorders	2012
[Human striatal D-neurons and their significance]. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2002, Volume: 22, Issue:4 Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Corpus Striatum; Dopamine; Droxidopa; Humans; Levodopa; Mental Disorders; Neurons; Norepinephrine; Parkinson Disease; Pluripotent Stem Cells	2002
[Various kinds of antiparkinson agents and their characteristics]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, Aug-10, Volume: 92, Issue:8 Topics: Animals; Antiparkinson Agents; Autonomic Nervous System Diseases; Catechol O-Methyltransferase Inhibitors; Cholinergic Antagonists; Dopamine Agonists; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors	2003
[Progressive subcortical gliosis]. Ryoikibetsu shokogun shirizu, 2003, Issue:40 Topics: Antipsychotic Agents; Cerebral Cortex; Diagnosis, Differential; Disease Progression; Gliosis; Humans; Levodopa; Mental Disorders	2003
Significance of human striatal D-neurons: implications in neuropsychiatric functions. Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:3 Topics: Animals; Antiparkinson Agents; Dopa Decarboxylase; Humans; Levodopa; Limbic System; Mental Disorders; Neostriatum; Nervous System Diseases; Neurons	2004
[Treatment of dementia with Lewy bodies]. Revue neurologique, 2006, Volume: 162, Issue:1 Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy	2006
Treatment of advanced Parkinson's disease. Expert review of neurotherapeutics, 2006, Volume: 6, Issue:8 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition Disorders; Humans; Levodopa; Mental Disorders; Parkinson Disease; Sleep Wake Disorders	2006
[Idiopathic Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2008, Volume: 76, Issue:2 Topics: Antiparkinson Agents; Deep Brain Stimulation; Humans; Hyperkinesis; Levodopa; Mental Disorders; Parkinson Disease; Physical Therapy Modalities	2008
Positron emission tomography of the brain: new possibilities for the investigation of human cerebral pathophysiology. Progress in neurobiology, 1984, Volume: 23, Issue:1-2 Topics: Aging; Amino Acids; Arterial Occlusive Diseases; Brain; Brain Ischemia; Brain Neoplasms; Carotid Artery Diseases; Cerebral Infarction; Cerebrovascular Disorders; Dementia; Epilepsy; Fluorine; Forecasting; Homeostasis; Humans; Huntington Disease; Isotopes; Levodopa; Mental Disorders; Models, Biological; Neurology; Oxygen Radioisotopes; Parkinson Disease; Radioisotopes; Receptors, Drug; Reference Values; Respiration; Tomography, Emission-Computed	1984
Anti-parkinsonian drugs today. Drugs, 1984, Volume: 28, Issue:3 Topics: Amantadine; Amphetamines; Antiparkinson Agents; Brain Chemistry; Catechol O-Methyltransferase Inhibitors; Dopamine beta-Hydroxylase; Droxidopa; Humans; Kinetics; Levodopa; Mental Disorders; Parasympatholytics; Parkinson Disease; Selegiline	1984
Adverse effects of antiparkinsonian drugs. Drugs, 1981, Volume: 21, Issue:5 Topics: Amantadine; Amphetamines; Antiparkinson Agents; Dyskinesia, Drug-Induced; Ergot Alkaloids; Humans; Hypotension; Levodopa; Mental Disorders; Parasympatholytics; Vomiting	1981
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias. Clinical neuropharmacology, 1997, Volume: 20, Issue:2 Topics: Antiparkinson Agents; Apomorphine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Globus Pallidus; Humans; Levodopa; Mental Disorders; Movement Disorders; Parkinson Disease; Sleep Wake Disorders; Stereotaxic Techniques; Thalamus	1997
[Psychiatric complications of L-dopa: physiopathology and treatment]. Revista de neurologia, 1997, Volume: 25 Suppl 2 Topics: Antidepressive Agents; Antiparkinson Agents; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroconvulsive Therapy; Humans; Incidence; Levodopa; Mental Disorders; Parkinson Disease	1997
[Arguments in favor of early treatment of Parkinson's disease with dopaminergic agonists]. Revue neurologique, 1999, Volume: 155, Issue:1 Topics: Antiparkinson Agents; Dopamine Agonists; Humans; Levodopa; Mental Disorders; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors; Treatment Outcome	1999
Parkinson's disease--levodopa complications. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1999, Volume: 26 Suppl 2 Topics: Antiparkinson Agents; Catechol O-Methyltransferase; Dopamine Agonists; Dyskinesia, Drug-Induced; Humans; Hypnotics and Sedatives; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors; Parkinson Disease	1999
A paradigm shift in brain research. Science (New York, N.Y.), 2001, Nov-02, Volume: 294, Issue:5544 Topics: Animals; Antipsychotic Agents; Brain; Brain Diseases; Cerebral Cortex; Corpus Striatum; Dopamine; Humans; Levodopa; Mental Disorders; Neurotransmitter Agents; Synaptic Transmission; Thalamus; Zimeldine	2001
Neurotransmitter interactions related to central dopamine neurons. Essays in neurochemistry and neuropharmacology, 1978, Volume: 3 Topics: Acetylcholine; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Central Nervous System; Dopamine; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Mental Disorders; Neural Pathways; Neurons; Neurotransmitter Agents; Norepinephrine; Parasympathetic Nervous System; Parkinson Disease; Serotonin	1978
Pharmaco-behavioral effects of hypothalamic peptides in animals and man: focus on thyrotropin-releasing hormone and neurotensin. Psychoneuroendocrinology, 1978, Volume: 3, Issue:3-4 Topics: Animals; Behavior, Animal; Body Temperature; Brain; Dihydroxyphenylalanine; Drug Synergism; Humans; Hypnotics and Sedatives; Hypothalamus; Levodopa; Mental Disorders; Neural Inhibition; Neurotensin; Neurotransmitter Agents; Serotonin; Thyrotropin-Releasing Hormone	1978
[Mental diseases symptomatic for internal affections. VI. Chemical agents]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Jun-13, Volume: 67, Issue:24 Topics: Alcoholism; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticonvulsants; Arsenic Poisoning; Carbon Monoxide Poisoning; Humans; Lead Poisoning; Levodopa; Mental Disorders; Mercury Poisoning; Psychotropic Drugs	1978
[The current treatment of Parkinson's disease]. Revue medicale de Liege, 1976, Oct-10, Volume: 31, Issue:19 Topics: Amantadine; Antidepressive Agents, Tricyclic; Dihydroxyphenylalanine; Drug Combinations; Histamine Antagonists; Humans; Levodopa; Mental Disorders; Movement Disorders; Neurosecretory Systems; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Pyridoxine; Stereotaxic Techniques	1976
Clinical pharmacokinetics of levodopa in parkinson's disease. Clinical pharmacokinetics, 1976, Volume: 1, Issue:5 Topics: Carboxy-Lyases; Cardiovascular Diseases; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gastric Mucosa; Gastrointestinal Diseases; Homovanillic Acid; Humans; Intestinal Absorption; Kinetics; Levodopa; Mental Disorders; Parkinson Disease; Pyridoxine; Stimulation, Chemical; Time Factors	1976
Optimization of levodopa therapy. Neurology, 1992, Volume: 42, Issue:1 Suppl 1 Topics: Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Sleep Wake Disorders	1992
Psychiatric side effects during the treatment of Parkinson's disease. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: Dreams; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa; Mental Disorders; Paranoid Disorders; Parkinson Disease; Serotonin; Severity of Illness Index; Sleep Wake Disorders	1988
Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality. Psychosomatics, 1986, Volume: 27, Issue:2 Topics: Antidepressive Agents; Clozapine; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Levodopa; Male; Mental Disorders; Nomifensine; Nortriptyline; Parkinson Disease; Personality; Psychotic Disorders; Serotonin; Tryptophan	1986

Trials

9 trial(s) available for levodopa and Behavior Disorders

Article	Year
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Movement disorders : official journal of the Movement Disorder Society, 2008, Nov-15, Volume: 23, Issue:15 Topics: Aged; Dopamine Agonists; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Mental Disorders; Movement Disorders	2008
L-tryptophan in the treatment of levodopa induced psychiatric disorders. Diseases of the nervous system, 1974, Volume: 35, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Brain; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Serotonin; Single-Blind Method; Treatment Outcome; Tryptophan	1974
Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease. Neurology, 1995, Volume: 45, Issue:3 Pt 1 Topics: Aged; Aged, 80 and over; Clozapine; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1995
Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group. Journal of neurosurgery, 1997, Volume: 86, Issue:6 Topics: Aged; Caudate Nucleus; Fetal Tissue Transplantation; Follow-Up Studies; Humans; Levodopa; Longitudinal Studies; Mental Disorders; Mesencephalon; Middle Aged; Motor Activity; Parkinson Disease; Postoperative Complications; Postoperative Period; Time Factors; Treatment Outcome	1997
Biology of schizophrenia: Mental effects of dopamine-beta-hydroxylase inhibition in normal men. Lancet (London, England), 1977, Jan-01, Volume: 1, Issue:8001 Topics: Clinical Trials as Topic; Dopamine beta-Hydroxylase; Fusaric Acid; Humans; Levodopa; Male; Mental Disorders; Picolinic Acids; Placebos; Schizophrenia	1977
The psychological effects of dopamine-beta-hydroxylase inhibition in normal subjects. Biological psychiatry, 1979, Volume: 14, Issue:3 Topics: Adult; Dopamine beta-Hydroxylase; Fusaric Acid; Humans; Levodopa; Male; Mental Disorders; Perception; Psychiatric Status Rating Scales; Social Behavior; Verbal Behavior	1979
Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology, 1976, Volume: 26, Issue:4 Topics: Adult; Aged; Delirium; Dementia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Tryptophan	1976
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease. Neurology, 1975, Volume: 25, Issue:10 Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease	1975
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study]. Revue neurologique, 1990, Volume: 146, Issue:2 Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Disorders; Randomized Controlled Trials as Topic	1990

Other Studies

66 other study(ies) available for levodopa and Behavior Disorders

Article	Year
Parkinson disease primer, part 2: management of motor and nonmotor symptoms. Canadian family physician Medecin de famille canadien, 2023, Volume: 69, Issue:2 Topics: Humans; Levodopa; Mental Disorders; Parkinson Disease; Quality of Life	2023
A man in his fifties with increasing motor fluctuations, sleep impairment and altered mental status. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2020, 10-13, Volume: 140, Issue:14 Topics: Antiparkinson Agents; Dyskinesias; Electroconvulsive Therapy; Humans; Levodopa; Male; Mental Disorders; Parkinson Disease; Sleep	2020
SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:10 Topics: Adult; Antiparkinson Agents; Brain; Cognition Disorders; Cohort Studies; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Mutation; Neuropsychological Tests; Organotechnetium Compounds; Parkinsonian Disorders; Proteins; Single-Blind Method; Statistics, Nonparametric; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed, Single-Photon; Tropanes; Young Adult	2018
Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life. Journal of the neurological sciences, 2018, 12-15, Volume: 395 Topics: Antiparkinson Agents; Apomorphine; Cognition; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Subcutaneous; Levodopa; Male; Mental Disorders; Middle Aged; Motor Activity; Neuropsychological Tests; Parkinson Disease; Quality of Life; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2018
Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:10 Topics: Activities of Daily Living; Adult; Age of Onset; Antiparkinson Agents; Cognition; Cohort Studies; Cross-Sectional Studies; Deep Brain Stimulation; Female; Follow-Up Studies; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease; Prognosis; Subthalamic Nucleus; Treatment Outcome	2013
Dopamine receptor dysregulation in hippocampus of aged rats underlies chronic pulsatile L-Dopa treatment induced cognitive and emotional alterations. Neuropharmacology, 2014, Volume: 82 Topics: Age Factors; Anhedonia; Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Cognition Disorders; Drug Combinations; Emotions; Hippocampus; Levodopa; Male; Mental Disorders; Motor Activity; Neurons; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D5; Spatial Learning	2014
UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset. Neuropharmacology, 2014, Volume: 82 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Benzodioxoles; Callithrix; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levodopa; Mental Disorders; Methylamines; Molecular Structure; Motor Activity; Parkinsonian Disorders; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors	2014
Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients. Drugs & aging, 2015, Volume: 32, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apathy; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Educational Status; Female; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Prospective Studies; Psychotropic Drugs; Spain	2015
Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate. Brain : a journal of neurology, 2015, Volume: 138, Issue:Pt 9 Topics: Aniline Compounds; Animals; Antiparkinson Agents; Brain; Brain Mapping; Chlorocebus aethiops; Disease Models, Animal; Dopamine; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Male; Mental Disorders; MPTP Poisoning; N-Methyl-3,4-methylenedioxyamphetamine; Nortropanes; Radionuclide Imaging; Serotonin; Serotonin Agents; Sulfides	2015
Factors responsible for early postoperative mental alterations after bilateral implantation of subthalamic electrodes. British journal of neurosurgery, 2017, Volume: 31, Issue:2 Topics: Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Deep Brain Stimulation; Electrodes, Implanted; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Postoperative Complications; Risk Factors; Subthalamic Nucleus; Third Ventricle	2017
Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity. Journal of neurology, 2009, Volume: 256, Issue:5 Topics: Antiparkinson Agents; Arm; Art; Benzothiazoles; Brain; Cabergoline; Creativity; Depressive Disorder; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Motor Skills; Obsessive Behavior; Paintings; Parkinson Disease; Pramipexole	2009
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. Journal of neurology, neurosurgery, and psychiatry, 2009, Volume: 80, Issue:8 Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Cohort Studies; Comorbidity; Disease Progression; Dopamine Agents; Dystonia; Female; GTP Cyclohydrolase; Hormones; Humans; Levodopa; Long-Term Care; Male; Mental Disorders; Middle Aged; Mutation; Treatment Outcome; Young Adult	2009
New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease. Neurobiology of aging, 2011, Volume: 32, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antibodies; Antiparkinson Agents; Apomorphine; Chemokine CX3CL1; Disease Models, Animal; DNA Nucleotidylexotransferase; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Levodopa; Male; Mental Disorders; Nerve Tissue Proteins; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reaction Time; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase	2011
Medical treatment of Parkinson disease. Neurologic clinics, 2009, Volume: 27, Issue:3 Topics: Amantadine; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Cognition Disorders; Corpus Striatum; Digestive System Physiological Phenomena; Dopamine Agonists; Enzyme Inhibitors; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors; Motor Activity; Movement Disorders; Neurons; Parkinson Disease; Sleep Wake Disorders; Substantia Nigra	2009
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease. Journal of neurology, 2011, Volume: 258, Issue:12 Topics: Aged; Antiparkinson Agents; Carbidopa; Cognition Disorders; Drug Combinations; Humans; Levodopa; Male; Mental Disorders; Parkinson Disease; Respiration Disorders	2011
Psychiatric symptoms screening in the early stages of Parkinson's disease. Journal of neurology, 2012, Volume: 259, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cognition; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Levodopa; Male; Mental Disorders; Neuropsychological Tests; Obsessive-Compulsive Disorder; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Surveys and Questionnaires	2012
Deep brain stimulation and behavioural changes: is comedication the most important factor? Neuro-degenerative diseases, 2012, Volume: 9, Issue:1 Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Female; Gambling; Humans; Impulsive Behavior; Levodopa; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Risk-Taking; Subthalamic Nucleus	2012
Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008. Pharmacopsychiatry, 2012, Volume: 45, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Child; Cross-Sectional Studies; Drug Interactions; Drug Prescriptions; Female; Humans; Inpatients; International Classification of Diseases; International Cooperation; Levodopa; Male; Mental Disorders; Middle Aged; Retrospective Studies; Time Factors; Young Adult	2012
Effect of deep brain stimulation on postencephalitic parkinsonism: a case report. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:8 Topics: Antiparkinson Agents; Brain; Combined Modality Therapy; Deep Brain Stimulation; Humans; Levodopa; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Ophthalmoplegia; Parkinson Disease, Postencephalitic; Subthalamic Nucleus	2012
Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:8 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cohort Studies; Color Perception; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Movement; Neurologic Examination; Parkinson Disease; Polysomnography; Psychomotor Performance; REM Sleep Behavior Disorder; Smell; Socioeconomic Factors	2012
Profile of multiple system atrophy in Moroccan patients attending a movement disorders outpatient clinic in Rabat university hospital. Revue neurologique, 2013, Volume: 169, Issue:2 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Amantadine; Disease Progression; Dopamine Agonists; Female; Hospitals, University; Humans; Hypotension, Orthostatic; Levodopa; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Morocco; Movement Disorders; Multiple System Atrophy; Outpatient Clinics, Hospital; Phenotype; Retrospective Studies; Sleep Disorders, Intrinsic; Symptom Assessment; Urination Disorders	2013
The spectrum of nonmotor symptoms in early Parkinson disease. Neurology, 2013, Jan-15, Volume: 80, Issue:3 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cognition; Cohort Studies; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Parkinson Disease; Surveys and Questionnaires	2013
Parkin disease: a phenotypic study of a large case series. Brain : a journal of neurology, 2003, Volume: 126, Issue:Pt 6 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Dystonia; Female; Genetic Predisposition to Disease; Humans; Levodopa; Ligases; Male; Mental Disorders; Middle Aged; Mutation; Parkinsonian Disorders; Pedigree; Phenotype; Polymerase Chain Reaction; Ubiquitin-Protein Ligases	2003
[Diagnosis and therapy for patients with Parkinson's disease (discussion)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, Aug-10, Volume: 92, Issue:8 Topics: Autonomic Nervous System Diseases; Disease Progression; Dopamine Agonists; Gait Disorders, Neurologic; Humans; Levodopa; Life Style; Low Back Pain; Mental Disorders; Neurosurgical Procedures; Parkinson Disease; Stereotaxic Techniques	2003
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism & related disorders, 2005, Volume: 11, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Catechols; Databases, Factual; Dopamine Agonists; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Multiple System Atrophy; Nitriles; Parkinson Disease; Pramipexole; Sexual Dysfunctions, Psychological; Thiazoles	2005
Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease. Archives of neurology, 2006, Volume: 63, Issue:9 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Disease Models, Animal; Dopamine Agonists; Drug Administration Routes; Drug Administration Schedule; Levodopa; Mental Disorders; Parkinsonian Disorders; Severity of Illness Index; Time Factors	2006
[Parkinson's disease and mental deterioration. Apropos of 30 cases]. Annales medico-psychologiques, 1983, Volume: 141, Issue:9 Topics: Adult; Aged; Female; Humans; Intelligence Tests; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Psychometrics; Rorschach Test	1983
Mental disorders in Parkinson's disease after treatment with L-DOPA. Advances in neurology, 1984, Volume: 40 Topics: Aged; Anxiety Disorders; Confusion; Delirium; Dementia; Depressive Disorder; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1984
Psychiatric complications of levodopa therapy of Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Circadian Rhythm; Hallucinations; Humans; Hydrocortisone; Levodopa; Mental Disorders; Mood Disorders; Parkinson Disease; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Thinking	1984
Pergolide in the treatment of Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Antiparkinson Agents; Domperidone; Ergolines; Humans; Levodopa; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Pergolide	1984
Recent advances in the treatment of Parkinson's disease. Acta neurologica Scandinavica. Supplementum, 1980, Volume: 78 Topics: Brain; Bromocriptine; Drug Therapy, Combination; Endorphins; Enkephalins; Humans; Levodopa; Mental Disorders; Parkinson Disease; Receptors, Dopamine	1980
Tryptophan deficiency stupor--a new psychiatric syndrome. Acta psychiatrica Scandinavica. Supplementum, 1982, Volume: 300 Topics: Aged; Animals; Carcinoid Tumor; Female; Humans; Levodopa; Malabsorption Syndromes; Male; Mental Disorders; Middle Aged; Muscles; Parkinson Disease; Serotonin; Syndrome; Tryptophan	1982
[Mental disorders in patients with Parkinson's disease treated with L-dopa]. La Clinica terapeutica, 1981, Jun-15, Volume: 97, Issue:5 Topics: Adult; Aged; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1981
[Various factors common to the pathogenesis of endogenous depression and chronic alcoholism]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1981, Volume: 81, Issue:9 Topics: 11-Hydroxycorticosteroids; Adolescent; Adult; Aged; Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Depressive Disorder; Dexamethasone; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Tryptophan	1981
Evaluation of Parkinson's disease. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Humans; Levodopa; Mental Disorders; Middle Aged; Parkinson Disease	1980
[Madopar in the treatment of paralysis agitans. I. Therapeutic efficacy and side-effects in 56 cases (author's transl)]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1980, Volume: 13, Issue:3 Topics: Adult; Benserazide; Electrocardiography; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1980
The impact of treatment with levodopa on Parkinson's disease. The Quarterly journal of medicine, 1980, Volume: 49, Issue:195 Topics: Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1980
Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences, 1996,Fall, Volume: 8, Issue:4 Topics: Adult; Aged; Depressive Disorder; Female; Homovanillic Acid; Humans; Kidney Failure, Chronic; Levodopa; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Psychotic Disorders; Renal Dialysis	1996
Switch-over from tolcapone to entacapone in severe Parkinson's disease patients. European neurology, 2001, Volume: 46, Issue:1 Topics: Aged; Antiparkinson Agents; Benzophenones; Catechols; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Nitriles; Nitrophenols; Parkinson Disease; Substance Withdrawal Syndrome; Tolcapone	2001
The clinical profile of nonmotor fluctuations in Parkinson's disease patients. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2002, Volume: 29, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Dopamine Agents; Humans; Levodopa; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease; Sensation Disorders; Surveys and Questionnaires; Time Factors	2002
Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes. Journal of the neurological sciences, 2002, Mar-30, Volume: 195, Issue:2 Topics: Age Factors; Aged; Brain; Clinical Trials as Topic; Electric Stimulation Therapy; Epilepsy; Female; Hematologic Diseases; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Motivation; Neurosurgical Procedures; Parkinson Disease; Patient Selection; Subthalamic Nucleus	2002
Levo-dopa in patients with post-encephalitic mental and extrapyramidal disorders. Indian journal of pediatrics, 1975, Volume: 42, Issue:328 Topics: Basal Ganglia Diseases; Child; Child, Preschool; Encephalitis, Japanese; Female; Humans; Levodopa; Male; Mental Disorders	1975
Behavioral side effects of medical drugs. Primary care, 1979, Volume: 6, Issue:2 Topics: Adrenal Cortex Hormones; Aged; Antihypertensive Agents; Antitubercular Agents; Aspirin; Behavior; Caffeine; Cimetidine; Contraceptives, Oral, Hormonal; Digitalis Glycosides; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levodopa; Male; Mental Disorders; Parasympatholytics; Placebos; Propranolol; Psychoses, Substance-Induced; Reserpine; Sympathomimetics; Thyroid Hormones	1979
Levodopa-induced dopaminergic hypersensitivity in the pathogenesis of psychiatric and neurologic disorders. International journal of neurology, 1979, Volume: 13, Issue:1-4 Topics: Adult; Aged; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Receptors, Dopamine	1979
Psychiatric disturbances occurring during levodopa therapy of Parkinson's disease. Primary care, 1977, Volume: 4, Issue:3 Topics: Humans; Levodopa; Mental Disorders; Parkinson Disease	1977
Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495). Neuropsychobiology, 1978, Volume: 4, Issue:1 Topics: Adjustment Disorders; Adult; Aged; Amphetamines; Anger; Antidepressive Agents; Bipolar Disorder; Bromocriptine; Depression; Female; Hostility; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Piperazines; Piribedil; Receptors, Dopamine; Syndrome	1978
Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases. Advances in biochemical psychopharmacology, 1977, Volume: 16 Topics: Apomorphine; Bromocriptine; Catecholamines; Depression; Dopamine; Homovanillic Acid; Humans; Levodopa; Mental Disorders; Neurons; Schizophrenia	1977
Problems in the treatment of Parkinsonism. Advances in experimental medicine and biology, 1977, Volume: 90 Topics: Antiparkinson Agents; Arteriosclerosis; Carbidopa; Diagnosis, Differential; Drug Combinations; Eye Manifestations; Humans; Levodopa; Mental Disorders; Movement Disorders; Parasympatholytics; Paresthesia; Parkinson Disease; Vision Disorders	1977
[Observations on the effect of levodopa in endogenous mental disorders]. Orvosi hetilap, 1976, Sep-12, Volume: 117, Issue:37 Topics: Humans; Levodopa; Mental Disorders	1976
[Modern antiparkinsonics (L-dopa and amantadine) and presentday psychiatry (author's transl)]. Ceskoslovenska psychiatrie, 1976, Volume: 72, Issue:6 Topics: Amantadine; Humans; Levodopa; Mental Disorders; Parkinson Disease, Secondary; Psychotic Disorders	1976
[Drug treatment of hyperkinesis and mental changes caused by levodopa]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1975, Jun-10, Volume: 95, Issue:16 Topics: Humans; Hyperkinesis; Levodopa; Mental Disorders; Parkinson Disease; Psychotropic Drugs	1975
[L dopa and mental disorders]. International journal of neurology, 1975, Volume: 10, Issue:1-4 Topics: Humans; Levodopa; Mental Disorders; Parkinson Disease	1975
Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy. International journal of neurology, 1975, Volume: 10, Issue:1-4 Topics: Humans; Levodopa; Mental Disorders; Parkinson Disease	1975
Parkinsonism, levodopa, and intelligence. International journal of neurology, 1975, Volume: 10, Issue:1-4 Topics: Adult; Aged; Female; Humans; Intelligence; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1975
Psychoneuroendocrine effects of methadone maintenance. Psychoneuroendocrinology, 1989, Volume: 14, Issue:5 Topics: Adrenocorticotropic Hormone; Adult; Energy Intake; Growth Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Male; Mental Disorders; Methadone; Middle Aged; Opioid-Related Disorders; Prolactin; Sexual Dysfunction, Physiological; Thyrotropin; Thyrotropin-Releasing Hormone; Water Deprivation	1989
[Development of Parkinson's disease]. La Revue du praticien, 1989, Mar-09, Volume: 39, Issue:8 Topics: Humans; Levodopa; Life Expectancy; Mental Disorders; Movement Disorders; Parkinson Disease; Prognosis	1989
[The mental state of parkinsonian patients]. La Revue du praticien, 1989, Mar-09, Volume: 39, Issue:8 Topics: Cognition Disorders; Dementia; Depression; Humans; Levodopa; Mental Disorders; Parkinson Disease	1989
Treatment of Parkinson's disease with subcutaneous lisuride infusions. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: Aged; Drug Eruptions; Drug Therapy, Combination; Ergolines; Female; Hematoma; Humans; Infusion Pumps; Levodopa; Lisuride; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease	1988
Lisuride infusion pump in Parkinson's disease. A report of two cases. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: Aged; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Lisuride; Mental Disorders; Parkinson Disease	1988
[Secondary effects of prolonged levodopa therapy in Parkinson's disease]. Medicina clinica, 1985, Jun-15, Volume: 85, Issue:3 Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1985
[Sleep: recent physiological acquisitions and clinical and pharmacological perspectives]. La Revue du praticien, 1974, Nov-11, Volume: 24, Issue:51 Topics: Animals; Brain; Cerebral Cortex; Electrocardiography; Electroencephalography; Electromyography; Electrooculography; Environment; Forecasting; Humans; Levodopa; Mental Disorders; Mesencephalon; Neurotransmitter Agents; Norepinephrine; Rats; Respiration; Reticular Formation; Sleep; Sleep Deprivation; Sleep Wake Disorders; Sleep, REM; Substance-Related Disorders; Telencephalon	1974
[Problems in the administration of L-DOPA (author's transl)]. Rivista di patologia nervosa e mentale, 1974, Volume: 95, Issue:4 Topics: Cardiovascular Diseases; Drug Eruptions; Gastrointestinal Diseases; Humans; Levodopa; Mental Disorders; Movement Disorders; Parkinson Disease; Urologic Diseases; Vision Disorders	1974
Appraisal of long-term levodopa treatment of parkinsonism with special reference to therapy limiting factors. Acta neurologica Scandinavica, 1974, Volume: 50, Issue:6 Topics: Aged; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease; Prognosis; Psychological Tests; Time Factors	1974
[L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1974, Volume: 74, Issue:5 Topics: Cardiovascular Diseases; Dyspepsia; Fear; Hallucinations; Humans; Hyperkinesis; Levodopa; Mental Disorders; Nausea; Parkinson Disease; Postoperative Care; Preoperative Care; Vomiting	1974
Idiopathic torsion dystonia (dystonia musculorum deformans). A review of forty-two patients. Brain : a journal of neurology, 1974, Volume: 97, Issue:4 Topics: Adolescent; Adult; Child; Child, Preschool; Chlorpromazine; Diagnostic Errors; Diazepam; Disability Evaluation; Dystonia Musculorum Deformans; Female; Gait; Globus Pallidus; Humans; Infant; Levodopa; Male; Mental Disorders; Middle Aged; Perphenazine; Phenothiazines; Prognosis; Remission, Spontaneous; Tetrabenazine; Thalamus; Trihexyphenidyl	1974
Psychiatric aspects of L-dopa therapy of Parkinson's disease. Psychiatry in medicine, 1972, Volume: 3, Issue:1 Topics: Adult; Aged; Delirium; Depression; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1972